Post-polio Syndrome

Post-polio syndrome (PPS), also referred to as post-poliomyelitis syndrome or post-polio sequelae, represents a collection of latent symptoms that arise after an initial poliomyelitis (polio) infection. These symptoms typically manifest 15 to 30 years following the acute phase of the infection and affect approximately 25–40% of polio survivors, with some data suggesting rates greater than 80%. The exact mechanism behind PPS remains unknown, but it is linked to the long-term damage inflicted by the poliovirus on the nervous system.

Signs and Symptoms

PPS is characterised by a gradual onset of symptoms following a period of stability post-polio infection. Key symptoms include:

• Muscular atrophy
• Weakness
• Pain
• Limb fatigue
• Problems with breathing or swallowing
• Sleep-related breathing disorders, such as sleep apnoea
• Decreased tolerance for cold temperatures

Fatigue is often the most debilitating symptom, with even minor exertion leading to significant tiredness and exacerbation of other symptoms. Increased activity levels between the initial infection and the onset of PPS can worsen symptoms. Early indicators might include subtle handwriting changes, although this needs further validation.

Mechanism

Several theories attempt to explain PPS, with the most accepted being "neural fatigue." Poliovirus targets specific neurons in the brainstem and spinal cord, killing many of the motor neurons that control muscles. Surviving neurons compensate by developing new nerve terminals, leading to enlarged motor units. Over time, the metabolic stress on these neurons may cause them to deteriorate, resulting in muscle weakness and paralysis. Age-related neuronal loss exacerbates this condition. Other theories include accelerated loss of remaining neurons and autoimmune reactions, although these have limited evidence compared to neural fatigue.

Diagnosis

Diagnosing PPS is challenging due to symptom overlap with the original polio infection and normal ageing. No specific laboratory tests exist for PPS. Diagnosis typically involves:

• Confirming a prior diagnosis of polio
• Noting a long interval after recovery
• Observing a gradual onset of new weakness

PPS diagnosis is often a process of exclusion, ruling out other potential causes for the symptoms. Neurological examinations, muscle strength assessments using scales like the Medical Research Council (MRC) scale, and advanced imaging techniques can help distinguish between old and new neuromuscular deficits.

Management

Treatment for PPS focuses on comfort and rest, as no curative therapies exist. Key management strategies include:

• Pain relief via analgesics
• Use of energy-saving devices like powered wheelchairs
• Lifestyle modifications to conserve energy, such as additional sleep, reduced workload, and weight management
• Muscle strength and endurance training
• Hydrotherapy

Medications like amantadine and pyridostigmine have proven ineffective in managing PPS fatigue. Intravenous immunoglobulin has shown modest promise but is insufficient as a standard treatment. Orthotic devices can help reduce energy expenditure, and strategies to manage joint pain and instability are very important. For those with severe respiratory involvement, rigorous respiratory therapy and possibly permanent ventilation may be necessary.

Prognosis

PPS is generally not life-threatening, except in cases with severe respiratory complications. There is no evidence of poliovirus recurrence or persistent infection in PPS patients. While some patients may experience substantial mobility and fatigue improvement over time, others may face significant physical limitations. The prognosis varies based on individual factors and the severity of the initial infection. A notable risk factor includes the use of anaesthesia during surgeries, which can abruptly worsen the condition.

Epidemiology

Earlier data suggested that PPS affects approximately 25 to 50% of polio survivors, but recent surveys indicate that up to 85% of respondents experience PPS symptoms. The syndrome typically appears 30–35 years after the initial infection, although cases with shorter and longer latency periods have been documented. Factors increasing PPS risk include the severity of the initial infection, time elapsed since infection, residual impairments, and being female. PPS can also occur in nonparalytic polio cases, with late-onset weakness and fatigue reported in 14–42% of these patients.

---

Self-assessment MCQs (single best answer)

What is Post-polio syndrome (PPS)?

How many years after the acute phase of polio infection do PPS symptoms typically manifest?

Which of the following is NOT a common symptom of PPS?

What is the most accepted theory explaining the mechanism behind PPS?

What is a key component in the diagnosis of PPS?

Which medication has shown modest promise in managing PPS but is not sufficient as a standard treatment?

Which of the following is NOT a recommended management strategy for PPS?

What is the prognosis of PPS in most cases?

Which factor increases the risk of developing PPS?

In what percentage of polio survivors do some data suggest PPS symptoms may manifest?